Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C047948 |
1'-acetoxychavicol acetate |
1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] | decreases reaction|increases expression | 15905586
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Butyrates results in increased expression of BCL2A1 mRNA] | decreases reaction|increases expression | 16256798
|
C026114 |
2-xylene |
2-xylene results in increased expression of BCL2A1 mRNA | increases expression | 20359517
|
D015081 |
2-Naphthylamine |
2-Naphthylamine results in increased expression of BCL2A1 mRNA | increases expression | 18247414
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of BCL2A1 mRNA | decreases expression | 19128835
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of BCL2A1 mRNA | increases expression | 17530438
|
C006632 |
arsenic trioxide |
[Tretinoin co-treated with arsenic trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
C006632 |
arsenic trioxide |
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
C006632 |
arsenic trioxide |
[Tretinoin co-treated with arsenic trioxide] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D001554 |
Benzene |
Benzene results in increased expression of BCL2A1 mRNA | increases expression | 20359517
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of BCL2A1 mRNA | decreases expression | 18247414
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of BCL2A1 mRNA | increases expression | 20106945
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of BCL2A1 mRNA | increases expression | 18180321
|
D002087 |
Butyrates |
[Tretinoin co-treated with arsenic trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D002087 |
Butyrates |
[Tretinoin co-treated with Butyrates] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D002087 |
Butyrates |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Butyrates results in increased expression of BCL2A1 mRNA] | decreases reaction|increases expression | 16256798
|
D002087 |
Butyrates |
Butyrates results in increased expression of BCL2A1 mRNA | increases expression | 16256798
|
C111238 |
carboxycinnamic acid bishydroxamide |
carboxycinnamic acid bishydroxamide results in decreased expression of BCL2A1 protein | decreases expression | 15897598
|
D002784 |
Cholesterol |
Cholesterol analog results in increased expression of BCL2A1 mRNA | increases expression | 19477266
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2A1 mRNA] | decreases reaction|increases expression | 16219905
|
D003474 |
Curcumin |
Curcumin results in decreased expression of BCL2A1 mRNA | decreases expression | 17596214
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of BCL2A1 mRNA | increases expression | 15951637 16847355
|
D004144 |
Diosgenin |
Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] | decreases reaction|increases expression | 16331273
|
D004144 |
Diosgenin |
Diosgenin results in decreased expression of BCL2A1 protein | decreases expression | 16331273
|
D004317 |
Doxorubicin |
BCL2A1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004317 |
Doxorubicin |
[Tretinoin results in increased expression of BCL2A1 mRNA] which results in decreased susceptibility to Doxorubicin | decreases response to substance|increases expression | 16572199
|
D004391 |
Dust |
Dust results in increased expression of BCL2A1 mRNA | increases expression | 17805423
|
C004912 |
ethylbenzene |
ethylbenzene results in increased expression of BCL2A1 mRNA | increases expression | 20359517
|
C049639 |
evodiamine |
evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] | decreases reaction|increases expression | 15710601
|
D011345 |
Fenofibrate |
Fenofibrate results in decreased expression of BCL2A1 mRNA | decreases expression | 20520642
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of BCL2A1 mRNA | decreases expression | 18035473
|
D005999 |
Glycochenodeoxycholic Acid |
Glycochenodeoxycholic Acid results in increased expression of BCL2A1 mRNA | increases expression | 15767249
|
C014026 |
hexamethylene bisacetamide |
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
C014026 |
hexamethylene bisacetamide |
[Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D017313 |
Fenretinide |
Fenretinide inhibits the reaction BCL2A1 protein | decreases reaction | 16230421
|
D017313 |
Fenretinide |
Fenretinide inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] | decreases reaction|increases expression | 16230421
|
C016517 |
indole-3-carbinol |
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] | decreases reaction|increases expression | 15811958
|
D007213 |
Indomethacin |
Indomethacin results in decreased expression of BCL2A1 mRNA | decreases expression | 17054584
|
D007213 |
Indomethacin |
Indomethacin results in decreased expression of BCL2A1 protein | decreases expression | 17054584
|
D007530 |
Isoflurane |
Isoflurane results in decreased expression of BCL2A1 mRNA | decreases expression | 16978161
|
C047382 |
kamebakaurin |
kamebakaurin inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] | decreases reaction|increases expression | 11877450
|
C011890 |
kojic acid |
kojic acid results in increased expression of BCL2A1 mRNA | increases expression | 16595896
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of BCL2A1 mRNA | increases expression | 15860229
|
C115354 |
lonafarnib |
lonafarnib inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] | decreases reaction|increases expression | 15090542
|
C019003 |
methaneselenol |
methaneselenol results in decreased expression of BCL2A1 mRNA | decreases expression | 19625696
|
D008752 |
Methylene Chloride |
Methylene Chloride results in increased expression of BCL2A1 mRNA | increases expression | 20359517
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of BCL2A1 mRNA | increases expression | 11830524
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of BCL2A1 mRNA | increases expression | 16780908
|
D009538 |
Nicotine |
Nicotine results in decreased expression of BCL2A1 mRNA | decreases expression | 18247414
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of BCL2A1 mRNA | increases expression | 17616710
|
C484027 |
oligofectamine |
oligofectamine results in increased expression of BCL2A1 mRNA | increases expression | 14668052
|
D010457 |
Peptidoglycan |
Peptidoglycan results in increased expression of BCL2A1 mRNA | increases expression | 15860229
|
C023617 |
pregna-4,17-diene-3,16-dione |
pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased expression of BCL2A1 mRNA] | decreases reaction|increases expression | 15322087
|
C059514 |
resveratrol |
resveratrol results in decreased expression of BCL2A1 protein | decreases expression | 17164350
|
C118258 |
SN50 peptide |
SN50 peptide results in decreased expression of BCL2A1 protein | decreases expression | 12466137
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of BCL2A1 mRNA | increases expression | 12016162
|
D013755 |
Tetradecanoylphorbol Acetate |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2A1 mRNA | affects cotreatment|affects expression | 16979875
|
D014050 |
Toluene |
Toluene results in increased expression of BCL2A1 mRNA | increases expression | 20359517
|
D014212 |
Tretinoin |
[Tretinoin co-treated with arsenic trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D014212 |
Tretinoin |
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D014212 |
Tretinoin |
[Tretinoin co-treated with arsenic trioxide] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D014212 |
Tretinoin |
[Tretinoin co-treated with Butyrates] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D014212 |
Tretinoin |
[Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA | affects cotreatment|increases expression | 12130515
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of BCL2A1 mRNA | increases expression | 16572199 12130515
|
D014212 |
Tretinoin |
[Tretinoin results in increased expression of BCL2A1 mRNA] which results in decreased susceptibility to Doxorubicin | decreases response to substance|increases expression | 16572199
|
D014241 |
Trichloroethylene |
Trichloroethylene results in increased expression of BCL2A1 mRNA | increases expression | 20359517
|
C111237 |
vorinostat |
vorinostat results in decreased expression of BCL2A1 protein | decreases expression | 15897598
|
C403304 |
zerumbone |
zerumbone results in decreased expression of BCL2A1 mRNA | decreases expression | 16007145
|
D015032 |
Zinc |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2A1 mRNA | affects cotreatment|affects expression | 16979875
|
C088658 |
zoledronic acid |
zoledronic acid results in decreased expression of BCL2A1 mRNA | decreases expression | 19036117
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.87 | 17190629 16889938 17202136 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
7.51 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
7.51 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
7.87 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
7.87 | 11954676 12718980 19131640 16100012 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
4.95 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
11.80 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
11.80 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
11.80 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
11.80 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
11.80 | 16537180 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
9.40 | 6695378 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
9.40 | 11497255 |
MESH:D000236 |
Adenoma |
|
resveratrol |
9.40 | 15688382 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.16 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.36 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.04 | 21441931 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.54 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.19 | 15955085 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.83 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
10.96 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
10.96 | 15579461 17627676 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
10.96 | 16627626 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
10.96 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
10.96 | 16410023 16325427 16580781 17119284 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.96 | 17661222 11369114 14761424 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.40 | 16916123 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.35 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
10.00 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
10.00 | 10388637 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.63 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.37 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.37 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
6.58 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
6.58 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
6.58 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.43 | 16456186 |
MESH:D001249 |
Asthma |
|
Zinc |
4.43 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
9.31 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
9.31 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
9.31 | 17967414 16873680 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
3.98 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.90 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.47 | 10684365 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
7.60 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
7.60 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
2-xylene |
5.38 | 7457028 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.69 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.16 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.47 | 17312309 15867366 19442620 16121404 11697798 16778634 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
8.23 | 11985600 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
8.23 | 16769263 8053405 11869084 18496637 15845617 18404659 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.49 | 11481608 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.18 | 17109824 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
14.06 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
14.06 | 12524144 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
14.06 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
12.14 | 17596214 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
12.14 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
12.14 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 17659439 16298037 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
13.06 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
13.06 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
13.06 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
13.06 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
13.06 | 19250217 18462866 18593918 16243823 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
13.06 | 15668708 17983394 19526202 16935488 11325840 15692762 18234424 17426702 18695136 15136595 15939500 18382427 16264153 17369602 16096432 16115903 18628466 15634643 16595493 15994142 15993339 15567936 16826403 16322301 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
13.06 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
indole-3-carbinol |
13.06 | 16082211 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
13.06 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Methylene Chloride |
13.06 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
13.06 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
13.06 | 16873071 16166294 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
13.06 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
vorinostat |
13.06 | 16144943 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
13.06 | 18695136 16096432 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.06 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.84 | 11589617 |
MESH:D002056 |
Burns |
|
Indomethacin |
4.19 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.48 | 16537180 11239499 15625704 15141370 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.27 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
3.42 | 18593918 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.62 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
12.37 | 14691202 15553829 16217749 15073043 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
12.37 | 17876044 16234567 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
12.37 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
12.37 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
12.37 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
12.37 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
12.37 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.46 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
9.67 | 11053908 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.67 | 16675471 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.82 | 14736730 18791128 11352223 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
5.26 | 18414057 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
5.26 | 19233551 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.34 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
9.40 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
9.40 | 17341418 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
9.40 | 18507039 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.66 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
34.54 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
34.54 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
34.54 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
34.54 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
34.54 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
34.54 | 12636206 15482327 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
34.54 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
34.54 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
34.54 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
34.54 | 16051514 16096774 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
34.54 | 16543248 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.17 | 16242529 17382496 17924179 17351982 17928571 15792986 16455267 16269455 17007740 15505089 16952015 18627295 16278810 15811867 17974986 16109756 17329180 16731534 15476868 16364871 17308081 16612575 17131338 16651473 17519947 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.74 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.40 | 15458977 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
6.40 | 16936243 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.77 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.62 | 19524636 20056578 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.32 | 9294310 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
11.22 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
11.22 | 16129372 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.63 | 11181007 |
MESH:D002779 |
Cholestasis |
|
Diosgenin |
4.79 | 16105132 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.62 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.43 | 9407595 |
MESH:D003092 |
Colitis |
|
Curcumin |
13.12 | 16782535 16804969 18200517 |
MESH:D003092 |
Colitis |
|
resveratrol |
13.12 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
13.12 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.07 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
7.33 | 15936596 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
7.33 | 16340194 19359593 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
7.33 | 15936596 15963497 15786552 15625704 11260862 15637740 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
7.33 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
5.77 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
5.77 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
5.77 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
5.77 | 11197048 17054584 18059344 12606626 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
5.77 | 16550006 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.38 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.40 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.68 | 12609071 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.18 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.54 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
6.54 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
6.54 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.54 | 9125849 17551590 9664655 10589399 14991402 9211117 16925845 9224671 8800419 9142499 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
6.54 | 19302082 |
MESH:D003643 |
Death |
|
Toluene |
5.13 | 6431079 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.61 | 15213294 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.25 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.19 | 16823706 16780908 11298694 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.76 | 16479319 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.34 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
2.56 | 18403477 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
7.76 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
7.76 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
6.92 | 7237001 7907874 |
MESH:D003967 |
Diarrhea |
|
vorinostat |
6.92 | 20479100 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
3.91 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
3.91 | 7120509 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.27 | 18602426 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.62 | 18446180 18043480 12774134 16133044 16326151 17190690 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
7.76 | 17351913 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
7.76 | 17045617 11991626 10671773 17351913 16699067 11535926 17202747 11595415 11595431 17151854 17329845 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
4.04 | 16707586 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.40 | 17881519 |
MESH:D004487 |
Edema |
|
Indomethacin |
9.04 | 7907874 8985016 16100529 19703484 8273558 7990266 10653021 |
MESH:D004487 |
Edema |
|
resveratrol |
9.04 | 8985016 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
9.04 | 16716910 9599246 11698051 8273558 7812673 15177302 8113982 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
3.93 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
7.74 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
7.74 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
10.55 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
10.55 | 16569247 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
10.55 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
3.69 | 15652904 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.62 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
8.90 | 18509659 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
8.90 | 17637181 15328337 15821434 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.21 | 10567023 16328016 17763956 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
10.66 | 17980183 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
10.66 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.55 | 11298111 |
MESH:D004938 |
Esophageal Neoplasms |
marker/mechanism |
|
| 17634542 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
12.05 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
12.05 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
12.05 | 11005569 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
12.05 | 15878914 15150132 15264214 15547733 16510608 16805852 15623463 15547721 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
12.05 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.18 | 16938888 9664655 |
MESH:D005221 |
Fatigue |
|
vorinostat |
5.07 | 20479100 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
6.51 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
6.51 | 19297423 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.30 | 16234978 |
MESH:D005334 |
Fever |
|
Indomethacin |
7.83 | 17627676 11852909 10431976 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
7.83 | 11852909 9205823 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.06 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.37 | 10962813 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
12.02 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
12.02 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.02 | 17994277 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.63 | 11298111 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.76 | 16904648 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
9.77 | 15046732 |
MESH:D005756 |
Gastritis |
|
Zinc |
9.77 | 17241300 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.18 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.15 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
18.48 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
18.48 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
18.48 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
18.48 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
18.48 | 17312396 |
MESH:D005910 |
Glioma |
|
Indomethacin |
3.00 | 16487511 18371953 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.86 | 11849393 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.82 | 11248219 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.61 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
15.46 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
15.46 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
15.46 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
15.46 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.62 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.65 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.65 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.11 | 16330681 17888722 18674790 16244371 16879835 12587719 17875725 16144979 16707910 16495754 14766674 18006777 16244372 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.31 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Zinc |
6.31 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.23 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.05 | 17241300 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.43 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.17 | 16183116 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.92 | 16366002 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
4.10 | 15633222 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.18 | 15135802 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.18 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
2-xylene |
4.51 | 7457013 7457028 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.52 | 17701891 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.66 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.02 | 15147373 18501091 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.02 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
10.86 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
10.86 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
10.86 | 16769263 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.18 | 17883296 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
4.57 | 18089816 19622757 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
12.83 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
12.83 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
12.83 | 17188708 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.48 | 12524144 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.05 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
7.88 | 17546600 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
7.88 | 16873680 |
MESH:D006973 |
Hypertension |
|
Benzene |
2.88 | 17940673 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.84 | 17488730 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.65 | 12669777 |
MESH:D007022 |
Hypotension |
|
Isoflurane |
4.46 | 12967683 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.49 | 10574470 18306037 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.82 | 10647630 10651667 16133968 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.83 | 16133044 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.13 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.63 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Curcumin |
16.11 | 16956363 18403477 17151092 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
16.11 | 17296493 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
16.11 | 3291741 7812673 12568917 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
16.11 | 12878042 17963957 17255318 9205823 17237260 |
MESH:D007249 |
Inflammation |
|
resveratrol |
16.11 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
16.11 | 11698051 8273558 7562506 15177302 7812673 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.98 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.01 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
2.93 | 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
8.18 | 15610444 11686837 10210152 11855677 18236018 15831440 11713966 17994277 17329856 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
8.18 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.76 | 10783313 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.83 | 15241188 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.14 | 17255318 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.12 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.43 | 15992940 17551590 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.49 | 10574470 16133968 18306037 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
11.88 | 16775033 15369732 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
11.88 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
11.88 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
11.88 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.61 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
8.61 | 16518626 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
4.58 | 17134702 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.08 | 18555241 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.47 | 12228301 10320625 11703811 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
20.93 | 12970779 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
20.93 | 15070760 |
MESH:D007938 |
Leukemia |
|
Benzene |
20.93 | 17119257 18335105 15935818 14694614 |
MESH:D007938 |
Leukemia |
|
Curcumin |
20.93 | 18462866 |
MESH:D007938 |
Leukemia |
|
SN50 peptide |
20.93 | 12970779 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
20.93 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.62 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
13.63 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
13.63 | 16106398 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
13.63 | 18089816 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.78 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
7.23 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
7.23 | 16572323 15631656 10785260 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
13.31 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
13.31 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
13.31 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
7.75 | 16968895 17050201 19850784 20471514 16467208 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
7.75 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
7.75 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
7.75 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
10.70 | 15748426 12712474 16331271 17649720 11161223 19035177 15336539 17217047 16330433 17712046 15622746 16112521 16966277 19642359 17869043 16891316 19225113 12018890 16823087 9834237 12679006 15213294 19075265 11468182 17107899 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
10.70 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
10.70 | 16331271 17294898 16766008 17361223 9834237 12679006 19035177 17506722 19075265 16823087 19642359 19225113 16788101 17649720 17712046 19029980 15748426 16891316 17339181 17301526 17107899 17217047 17368321 16935935 16140955 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
10.04 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
10.04 | 16106398 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.83 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.18 | 17980183 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.17 | 15821434 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.50 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.92 | 9224671 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.18 | 11479899 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
7.63 | 17355460 18705752 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
7.63 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
7.63 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
7.63 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
7.63 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
7.63 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
2.48 | 16956363 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
15.01 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
15.01 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
15.01 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
15.01 | 19321006 19073162 20405173 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
15.01 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
zerumbone |
15.01 | 20452335 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
18.92 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
18.92 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
18.92 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
18.92 | 18775883 18253720 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
18.92 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
18.92 | 7955063 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.94 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.81 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.27 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.50 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
13.67 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
13.67 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
13.67 | 20869020 17053015 18520028 20464547 6695378 18569708 20064080 18816296 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
13.67 | 19359593 16243823 18462866 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
13.67 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
13.67 | 11497255 11053908 16537180 |
MESH:D008175 |
Lung Neoplasms |
|
Methylene Chloride |
13.67 | 15172992 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
13.67 | 16712894 15276417 17306315 19931552 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
13.67 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Benzene |
10.46 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
10.46 | 18462866 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
10.46 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.81 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.44 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.44 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
9.85 | 16173963 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
9.85 | 15621674 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
vorinostat |
5.17 | 20479100 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
8.50 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
8.50 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
23.10 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
23.10 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
23.10 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
23.10 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
23.10 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
23.10 | 12773700 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
23.10 | 17312309 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.55 | 17453147 |
MESH:D008545 |
Melanoma |
|
Curcumin |
10.92 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
10.92 | 16827129 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
10.92 | 16270382 |
MESH:D008545 |
Melanoma |
|
resveratrol |
10.92 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
10.92 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
10.92 | 16752155 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.66 | 17263510 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.91 | 16940565 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
3.45 | 9294310 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
9.22 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
hexamethylene bisacetamide |
9.22 | 15543656 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
9.22 | 16675582 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.90 | 17112576 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
3.29 | 11903285 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.02 | 15792986 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.75 | 9294310 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
12.14 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
12.14 | 16274795 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
12.14 | 12636206 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.26 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
23.29 | 15949261 11468182 14977855 19549372 19417148 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
23.29 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
23.29 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
lonafarnib |
23.29 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
23.29 | 17164350 17049120 16267019 16490592 14749477 17935668 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
23.29 | 19621390 18089719 16996129 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
10.66 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
10.66 | 17962980 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.13 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.32 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.32 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.22 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.22 | 16525036 17015251 17188708 16317513 17125593 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
3.59 | 17015251 17125593 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.23 | 17322642 |
MESH:D009325 |
Nausea |
|
vorinostat |
4.99 | 20479100 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
8.66 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
8.66 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.36 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
8.36 | 11053908 11239499 16537180 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
8.36 | 19139120 15867366 17312309 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
16.10 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
16.10 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
16.10 | 16365874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
16.10 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
16.10 | 16594593 16946489 |
MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
16.10 | 11911487 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
12.39 | 10663608 15625704 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
12.39 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
12.39 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
4.00 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
4.47 | 16365874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.25 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.55 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
8.13 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
8.13 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.09 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
14.42 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
14.42 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
14.42 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
14.42 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
2.97 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
7.31 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.31 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.91 | 17929310 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.15 | 16303764 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
5.19 | 20557099 9802331 |
MESH:D009765 |
Obesity |
|
Curcumin |
2.60 | 19297423 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.63 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
3.72 | 15612468 15727169 17479406 15935809 17178637 17119257 16737584 15913788 15576619 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
3.33 | 7009135 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
4.84 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
6.51 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
6.51 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.77 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.69 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.46 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
19.91 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
19.91 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
19.91 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
19.91 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
19.91 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
19.91 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
19.91 | 16936753 |
MESH:D010146 |
Pain |
|
Indomethacin |
9.01 | 17440234 17627676 13679232 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
9.01 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
9.01 | 16475674 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
4.14 | 12538197 18702446 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
14.00 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
14.00 | 19196508 17440100 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
14.00 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
14.00 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
14.00 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.44 | 15028970 17883296 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
3.78 | 18404319 12065085 8330346 18922899 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.67 | 19927285 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.18 | 16537180 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.66 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.18 | 11903285 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.62 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.38 | 17225004 |
MESH:D010538 |
Peritonitis |
|
Isoflurane |
4.71 | 17414419 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.62 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.62 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.03 | 11605937 12224865 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.76 | 17114810 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.61 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.12 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.12 | 16679765 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.25 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.73 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
5.39 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
5.39 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
5.39 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
5.39 | 15754350 16289102 18247401 16644109 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
5.39 | 18226269 18769126 18156803 12497104 11398177 10851300 15129424 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
5.39 | 16729912 15897917 18437689 15749863 16888761 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
5.39 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
5.39 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
5.39 | 17804756 17718901 17636462 15767336 17675339 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
5.39 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
vorinostat |
5.39 | 17218635 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
5.39 | 16700911 16517595 16606632 12429649 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
5.39 | 19103299 12438248 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
7.72 | 11849393 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
7.72 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.26 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.26 | 10548101 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.07 | 19168576 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.71 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.04 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
2.99 | 17058453 16314181 15827377 17520802 16317513 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
3.54 | 10666014 18379247 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.37 | 10835634 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
8.05 | 16303925 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
8.05 | 16584753 |
MESH:D012175 |
Retinoblastoma |
|
SN50 peptide |
5.96 | 12466137 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.61 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
8.04 | 18462866 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
8.04 | 15675481 17203757 17710206 18313854 15625365 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
14.46 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
14.46 | 16326096 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
14.46 | 16121404 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.26 | 17846226 |
MESH:D012640 |
Seizures |
|
Nicotine |
5.56 | 17873105 |
MESH:D012640 |
Seizures |
|
Toluene |
5.56 | 6431079 9294310 |
MESH:D018805 |
Sepsis |
|
Curcumin |
8.37 | 18389075 |
MESH:D018805 |
Sepsis |
|
Isoflurane |
8.37 | 17414419 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
23.01 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
23.01 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
23.01 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
23.01 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
23.01 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
23.01 | 11807781 18404319 8330346 12065085 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
23.01 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.05 | 16767912 17203757 15625365 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.38 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
3.89 | 16280098 10486359 17638125 10215738 10192188 17160473 18545984 15472012 16184426 17207306 18209964 15038085 16113693 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
7.36 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
7.36 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
7.36 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
7.36 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
7.36 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
7.36 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
6.03 | 19188055 16631530 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
6.03 | 11523592 16755016 10750652 17977527 12500499 17627676 18193104 18431645 15255614 11906479 18237397 1323529 16169175 15104355 18299717 17918041 12787963 15138204 12467913 12077510 14567935 16397915 18543354 16631530 16150113 10878458 11595415 18209962 18087811 18181030 17657623 17654042 17135157 18726076 11729361 16934674 16252198 17895592 11145282 11595431 12498302 10423059 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.02 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.46 | 16045194 16684133 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.43 | 10048760 10514026 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
8.60 | 15821434 |
MESH:D013921 |
Thrombocytopenia |
|
vorinostat |
8.60 | 20479100 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.43 | 10850423 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
18.20 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
18.20 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
18.20 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
18.20 | 18791128 14736730 11352223 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
18.20 | 17045167 16026305 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.34 | 16785264 16720336 11259349 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
4.93 | 15735609 18041664 18305452 17979512 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
13.98 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
13.98 | 16051514 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
13.98 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.44 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.88 | 16040207 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.37 | 17380554 10574470 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
20.52 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
20.52 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
20.52 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
20.52 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
20.52 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
20.52 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
20.52 | 17306315 16452187 16712894 11723127 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.73 | 18462866 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
24.81 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
indole-3-carbinol |
24.81 | 16082211 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
24.81 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
24.81 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
24.81 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.47 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
8.22 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.22 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.07 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.90 | 17056641 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
8.63 | 17638931 17334414 17678736 16364871 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.63 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.56 | 16761959 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.21 | 11897121 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.52 | 16287080 |